Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bio-Rad Laboratories, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BIO
New York
3840
www.bio-rad.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bio-Rad Laboratories, Inc.
Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline
- Feb 6th, 2025 3:00 pm
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance
- Feb 6th, 2025 12:21 pm
Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?
- Feb 4th, 2025 2:40 pm
Bio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy?
- Jan 28th, 2025 7:41 pm
Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025
- Jan 27th, 2025 10:00 pm
Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
- Jan 17th, 2025 2:40 pm
Why Bio-Rad Stock is an Apt Pick for Your Portfolio Right Now
- Jan 17th, 2025 11:14 am
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
- Jan 8th, 2025 1:15 pm
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
- Jan 2nd, 2025 9:30 pm
At US$331, Is It Time To Put Bio-Rad Laboratories, Inc. (NYSE:BIO) On Your Watch List?
- Dec 26th, 2024 1:47 pm
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound?
- Nov 29th, 2024 4:31 pm
Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
- Nov 29th, 2024 12:43 pm
Bio-Rad Laboratories, Inc. (BIO): A Bull Case Theory
- Nov 25th, 2024 1:05 am
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
- Nov 21st, 2024 2:00 pm
What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?
- Nov 13th, 2024 1:46 pm
Interpreting Bio-Rad (BIO) International Revenue Trends
- Nov 4th, 2024 2:15 pm
Bio-Rad Laboratories, Inc. (NYSE:BIO) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
- Nov 2nd, 2024 12:23 pm
Bio-Rad Laboratories Third Quarter 2024 Earnings: EPS: US$23.37 (vs US$3.65 in 3Q 2023)
- Nov 1st, 2024 10:43 am
Q3 2024 Bio Rad Laboratories Inc Earnings Call
- Oct 31st, 2024 4:36 pm
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
- Oct 31st, 2024 1:00 pm
Scroll